Detall de la convocatòria

Expressió d'interès - Expression of interest

Característiques

Característica
Objectiu de la convocatòria
The Technology Impact Award provides seed funding to address the gap between conceptual technological innovation and real-world clinical application. By encouraging collaboration between technology developers and clinical cancer immunologists, CRI hopes to accelerate the creation of technologies that can generate proof-of-principle data and unlock novel biological insights.
Característiques principals
The grant is designed to support early-stage, pre-development concepts—innovations that have not yet been built or tested, but that hold the potential to transform the landscape of cancer immunotherapy. Such technologies may include, but are not limited to, computational systems biology approaches, advanced cancer (or molecular) profiling technologies, real-time visualization technologies, complex multicellular culture systems and novel therapeutic technologies.
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Convocatòria (URL)
https://www.cancerresearch.org/technology-impact-award
Requisits
  • Applicants must hold a tenure-track position at a not for profit research center or institution.
  • Clinical cancer immunologists and technology developers are encouraged to collaborate.
  • Co-PIs are eligible and encouraged to apply.
  • Selected projects that meet their 12 and 24 month milestones may be eligible for follow-on funding that will enable the established proof-of-concept technology to be developed into a methodology that improves cancer immunotherapy research worldwide.
    • Dotació
    $600.000
    Durada
    2-4 years
    Documentació
    Letters of intent must be submitted electronically at: https://cri.us-1.smartsimple.com/s_Login.jsp
    Supporting documentation:
    After you have filled out all required fields on the online form, you will be asked to upload the following five items as individual PDF documents.
  • An initial research concept (succinct description of the proposed research plan with specific aims and timelines, description of how the proposed technology platform has the potential to transform the field of cancer immunotherapy), not to exceed 3 pages.
  • Brief description of your current research.
  • Curriculum vitae and bibliography (limit bibliography to past 5 years or publications relevant to proposed research).
  • If applicable, curriculum vitae for all group members, as well as a description of each member’s research focus.
  • Any documents you attach to your online application form must be typed single-space using a 12 point or larger font size.
    • AVÍS IMPORTANT
    This grant follows as a two-stage:
  • Letter of Intent: Deadline November 15, 2025
  • Full Application: Deadline March 1, 2026

    Candidates will be notified by mid-February whether they have been invited to submit a full grant proposal. Applications are due by 5 p.m. Eastern Time on these dates. If these deadlines fall on the weekend, applications will be accepted the following Monday.

    • Arxius

    Arxiu
    TECH_Terms_2022-10_-_web.pdf
    Annual-Invention-Update-Form-1-2025.pdf
    CRI-Invention-Disclosure-Form-1-2025.pdf
    Revenue-Sharing-Agreement.pdf